Clinical Trial

Treatment of Moderate to Severe Glabellar Lines

Study Description

Treatment of Moderate to Severe Glabellar Lines

The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe GL.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Biological - botulinum toxin

neuromodulator to be injected in the GL region

Biological - Placebo

Placebo to be injected in the GL area

Additional Information

Official Study Title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Clinical Trial ID

NCT04249583

ParticipAid ID

aQWYqd